Aventis Inc.
Aventis Inc., a prominent player in the biotechnology and pharmaceutical industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in innovative drug development and biopharmaceutical solutions, with a strong operational presence across North America and Europe.
Specialising in cutting-edge therapies for chronic diseases, Aventis Inc. is renowned for its unique approach to personalised medicine, which sets it apart from competitors. The company has achieved significant milestones, including the successful launch of several groundbreaking treatments that have transformed patient care.
With a commitment to research and development, Aventis Inc. continues to enhance its market position, earning accolades for its contributions to healthcare and its dedication to improving patient outcomes.
+60 vs industry average
Aventis Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Aventis Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Aventis Inc. yet.
Aventis Inc.'s reported carbon emissions
Aventis Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Sanofi, from which it inherits climate commitments and initiatives.
Aventis Inc. aligns its climate strategy with Sanofi's sustainability goals, which include participation in various initiatives such as the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 commitment to renewable energy. These initiatives reflect a commitment to reducing greenhouse gas emissions and transitioning to sustainable energy sources.
While specific reduction targets for Aventis Inc. are not detailed, the overarching goals set by Sanofi provide a framework for emissions reduction and climate action. As a current subsidiary of Sanofi, Aventis Inc. benefits from the parent company's established climate strategies and performance metrics, which aim to enhance sustainability across its operations.
In summary, while Aventis Inc. does not have specific emissions data or reduction targets available, it is committed to climate action through its association with Sanofi, leveraging inherited initiatives to drive sustainability efforts.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Aventis Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Aventis Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project